{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:58:01Z","timestamp":1740149881232,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"DOI":"10.1007\/s10006-024-01264-9","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T04:12:40Z","timestamp":1717215160000},"page":"1423-1429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mycosis fungoides refractory to treatment \u2013 importance of a multidisciplinary approach"],"prefix":"10.1007","volume":"28","author":[{"given":"Mariana Pires","family":"Feletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria de Almeida","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius Matos","family":"Novo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Scopel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Filipe da Paz","family":"Scardua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibia Soraya","family":"Marcondes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Resende","family":"Camisasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6865-7955","authenticated-orcid":false,"given":"T\u00e2nia Regina","family":"Gr\u00e3o-Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"issue":"6","key":"1264_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/annonc\/mdt242","volume":"24","author":"R Willemze","year":"2013","unstructured":"Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M (2013) Primary cutaneous lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(6):149\u2013156. https:\/\/doi.org\/10.1093\/annonc\/mdt242","journal-title":"Ann Oncol"},{"issue":"6","key":"1264_CR2","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s13555-021-00625-6","volume":"11","author":"E Lebas","year":"2021","unstructured":"Lebas E, Collins P, Somja J, Nikkels AF (2021) A Comprehensive Update of the atypical, rare and mimicking presentations of Mycosis Fungoides. Dermatol Ther (Heidelb) 11(6):1931\u20131951. https:\/\/doi.org\/10.1007\/s13555-021-00625-6","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1264_CR3","doi-asserted-by":"publisher","unstructured":"Bayramg\u00fcrler D, Kazan D, Eruyar T, Demirkesen C, Demirba\u015f A (2022) The oral cavity and gastric involvement in mycosis fungoides while on systemic bexarotene therapy: a rare case report. Dermatol Ther 35(4). https:\/\/doi.org\/10.1111\/dth.15349","DOI":"10.1111\/dth.15349"},{"issue":"5","key":"1264_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4103\/0378-6323.42644","volume":"74","author":"YK Inchara","year":"2008","unstructured":"Inchara YK, Rajalakshmi T (2008) Early mycosis fungoides vs. inflammatory mimics: how reliable is histology? Indian J Dermatol Venereol Leprol 74(5):462\u2013466. https:\/\/doi.org\/10.4103\/0378-6323.42644","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"1264_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/DAD.0000000000000379","volume":"37","author":"M Abdel-Halim","year":"2015","unstructured":"Abdel-Halim M, El-Nabarawy E, El Nemr R, Hassan AM (2015) Frequency of hypopigmented mycosis fungoides in Egyptian patients presenting with hypopigmented lesions of the trunk. Am J Dermatopathol 37(11):834\u2013840. https:\/\/doi.org\/10.1097\/DAD.0000000000000379","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"1264_CR6","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1111\/jocd.14528","volume":"21","author":"B Farabi","year":"2022","unstructured":"Farabi B, Seminario-Vidal L, Jamgochian M, Akay BN, Atak MF, Rao BK, Karagaiah P, Grabbe S, Goldust M (2022) Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials. J Cosmet Dermatol Jul 21(7):2742\u20132748. https:\/\/doi.org\/10.1111\/jocd.14528","journal-title":"J Cosmet Dermatol Jul"},{"key":"1264_CR7","doi-asserted-by":"crossref","unstructured":"Feldman AM, Sevak P, McHargue C, Lim HW, Siddiqui F (2017) Mycosis fungoides involving head and neck mucosal sites: review of the literature. Appl Rad Oncol (2):11\u201319","DOI":"10.37549\/ARO1122"},{"issue":"3","key":"1264_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12105-018-0923-5","volume":"13","author":"MS Rosebush","year":"2019","unstructured":"Rosebush MS, Allen CM, Accurso BT, Baiocchi RA, Cordell KG (2019) Oral mycosis fungoides: a report of three cases and review of the literature. Head Neck Pathol 13(3):492\u2013499. https:\/\/doi.org\/10.1007\/s12105-018-0923-5","journal-title":"Head Neck Pathol"},{"key":"1264_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/cia2.12330","volume":"6","author":"S Hayashi","year":"2023","unstructured":"Hayashi S, Tokoro S, Igawa K (2023) Brentuximab vedotin treatment for mycosis fungoides with CD30\u2009+\u2009large-cell transformation in the early stage. J Cutan Immunol Allergy 6:260\u2013261. https:\/\/doi.org\/10.1002\/cia2.12330","journal-title":"J Cutan Immunol Allergy"},{"issue":"1","key":"1264_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.hoc.2018.09.001","volume":"33","author":"C Larocca","year":"2019","unstructured":"Larocca C, Kupper T (2019) Mycosis Fungoides and S\u00e9zary Syndrome: an update. Hematol Oncol Clin North Am 33(1):103\u2013120. https:\/\/doi.org\/10.1016\/j.hoc.2018.09.001","journal-title":"Hematol Oncol Clin North Am"},{"issue":"23","key":"1264_CR11","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1182\/bloodadvances.2021004710","volume":"5","author":"SM Horwitz","year":"2021","unstructured":"Horwitz SM, Scarisbrick JJ, Dummer R et al (2021) Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician\u2019s choice in cutaneous T-cell lymphoma: final data. Blood Adv 5(23):5098\u20135106. https:\/\/doi.org\/10.1182\/bloodadvances.2021004710","journal-title":"Blood Adv"},{"issue":"10094","key":"1264_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","volume":"390","author":"HM Prince","year":"2017","unstructured":"Prince HM, Kim YH, Horwitz SM et al (2017) Brentuximab vedotin or physician\u2019s choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet 390(10094):555\u2013566. https:\/\/doi.org\/10.1016\/S0140-6736(17)31266-7","journal-title":"Lancet"},{"issue":"11","key":"1264_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s11912-023-01464-8","volume":"25","author":"S Morgenroth","year":"2023","unstructured":"Morgenroth S, Roggo A, Pawlik L, Dummer R, Ramelyte E (2023) What is New in cutaneous T cell lymphoma? Curr Oncol Rep 25(11):1397\u20131408. https:\/\/doi.org\/10.1007\/s11912-023-01464-8","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"1264_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.det.2015.06.001","volume":"33","author":"EA Olsen","year":"2015","unstructured":"Olsen EA (2015) Evaluation, diagnosis, and staging of cutaneous lymphoma. Dermatol Clin 33(4):643\u2013654. https:\/\/doi.org\/10.1016\/j.det.2015.06.001","journal-title":"Dermatol Clin"},{"key":"1264_CR15","doi-asserted-by":"publisher","unstructured":"Wright JM, Balciunas BA, Muus JH Mycosis fungoides with oral manifestations (1981) oral surgery, oral medicine. Oral Pathol 51(1):24\u201331. https:\/\/doi.org\/10.1016\/0030-4220(81)90122-5","DOI":"10.1016\/0030-4220(81)90122-5"},{"key":"1264_CR16","doi-asserted-by":"publisher","unstructured":"Goldsmith SM, Seo BL, Kumara De Silva R, Parachuru P, Rich AM, Seymour GJ (2014) Oral mycosis fungoides: report with immune profile. Oral Surg Oral Med Oral Pathol Oral Radiol 118(2). https:\/\/doi.org\/10.1016\/j.oooo.2013.10.005","DOI":"10.1016\/j.oooo.2013.10.005"},{"key":"1264_CR17","unstructured":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2017)"},{"issue":"12","key":"1264_CR18","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","volume":"33","author":"JT Edinger","year":"2009","unstructured":"Edinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH (2009) CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol 33(12):1860\u20131868. https:\/\/doi.org\/10.1097\/PAS.0b013e3181bf677d","journal-title":"Am J Surg Pathol"},{"key":"1264_CR19","doi-asserted-by":"publisher","unstructured":"De Coninck EC, Kim YH, Varghese A, Hoppe RT (2001) Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. J Clin Oncol 19(3):779\u2009\u2013\u200984. https:\/\/doi.org\/10.1200\/JCO.2001.19.3.779. PMID: 11157031","DOI":"10.1200\/JCO.2001.19.3.779"},{"key":"1264_CR20","unstructured":"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides. Richard T Hoppe, MDYoun H Kim, Timothy M Kuzel, MD, FACPJohn A Zic,Alan G Rosmarin, MDRosamaria Corona, MD, DSc. UPTODATE. Accessed 09 may, 2024"},{"issue":"32","key":"1264_CR21","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","volume":"33","author":"M Duvic","year":"2015","unstructured":"Duvic M, Tetzlaff MT, Gangar P, Clos AL, Sui D, Talpur R (2015) Results of a phase II trial of Brentuximab Vedotin for CD30 + cutaneous T-Cell lymphoma and Lymphomatoid Papulosis. J Clin Oncol 33(32):3759\u20133765. https:\/\/doi.org\/10.1200\/JCO.2014.60.3787","journal-title":"J Clin Oncol"},{"key":"1264_CR22","first-page":"1","volume":"5","author":"E Litovchenko","year":"2022","unstructured":"Litovchenko E, De Oliveira AC (2022) Micose fungoide com dissemina\u00e7\u00e3o linf\u00e1tica. BWS J 5:1\u20139 Accessed 31 Ago, 2023. https:\/\/bwsjournal.emnuvens.com.br\/bwsj\/article\/view\/310\/174","journal-title":"BWS J"},{"issue":"32","key":"1264_CR23","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1200\/JCO.2014.60.396","volume":"33","author":"YH Kim","year":"2015","unstructured":"Kim YH, Tavallaee M, Sundram U et al (2015) Phase II investigator-initiated study of Brentuximab Vedotin in Mycosis Fungoides and S\u00e9zary Syndrome with variable CD30 expression level: a Multi-institution Collaborative Project. J Clin Oncol 33(32):3750\u20133758. https:\/\/doi.org\/10.1200\/JCO.2014.60.396","journal-title":"J Clin Oncol"},{"issue":"3","key":"1264_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00130404-200205000-00008","volume":"8","author":"SF Wong","year":"2002","unstructured":"Wong SF, Wilder-Smith P (2002) Pilot study of laser effects on oral mucositis in patients receiving chemotherapy. Cancer J 8(3):247\u2013254. https:\/\/doi.org\/10.1097\/00130404-200205000-00008","journal-title":"Cancer J"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-024-01264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-024-01264-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-024-01264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T20:17:47Z","timestamp":1723925867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-024-01264-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s10006-024-01264-9","relation":{},"ISSN":["1865-1569"],"issn-type":[{"type":"electronic","value":"1865-1569"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee in Research with Human Beings with CAAE: 61277222.0.0000.5060.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent to publish the image in Fig.\u00a0.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}